Medical News

FDA Finds No Heart Attack Risk With HIV Drug

From U.S. Centers for Disease Control and Prevention

March 2, 2011

Food and Drug Administration officials said Tuesday that a data review of the AIDS drug abacavir revealed no greater risk of heart attacks than other HIV medicines. Doctors should continue to prescribe abacavir as directed, the agency said. FDA's analysis included 26 clinical trials and began in 2008 after studies showed conflicting information about a possible link to heart attacks. Abacavir, a nucleoside reverse transcriptase inhibitor, is in the combination treatments Ziagen, Trizivir, and Epzicom.

Back to other news for March 2011

Adapted from:
Reuters
03.01.2011

Approval of Generic Abacavir Tablets, 300 mg

Ongoing Abacavir Safety Review Finds No Increased Risk of Heart Attack

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.

FDA Report Suggests Abacavir May Not Increase Myocardial Infarction Risk After All

No comments have been made.

Add Your Comment:

(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

FDA Report Suggests Abacavir May Not Increase Myocardial Infarction Risk After All

HIV Management Today: Mental Health & HIV, the Uncharted Territory

Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure

10 Top Studies Whose Impact Will Last Well Beyond CROI 2013

PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013

HIV Opportunistic Infection Guidelines Updated

More >>

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.